Table 1.
Baseline characteristics of 54 patients who received conversion hepatectomy for initially unresectable colorectal liver metastases
| Age median (range), years | 65 (35-83) |
| Male, n (%) | 31 (58%) |
| Platelet count, median (range), × 104/μL | 19.1 (6.5-37.5) |
| Total bilirubin, median (range) mg/dL | 0.7 (0.3-1.3) |
| Serum albumin, median (range), g/L | 3.9 (3.0-4.4) |
| Prothrombin activity (%) | 108 (54-137) |
| Serum CEA level, ng/mL | 6.1 (1.0-172.6) |
| Size of largest tumor, median (range), mm | 25.5 (5-160) |
| Solitary tumor, n (%) | 15 (28%) |
| Tumor number, median (range) | 2.5 (1-19) |
| Synchronous/Metachronous | 34/19 |
| Molecular targets (present), n (%) | 27 (50%) |
| Chemotherapy cycles | 6 (2-38) |
| RECIST CR/PR/SD/PD | 2/32/15/5 |
CEA, carcinoembryonic antigen; CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease.